NuCana plc NCNA
$ 1.2
-0.83%
Quarterly report 2022-Q2
added 08-17-2022
Country |
Britain |
IPO year |
2017 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Mr. Hugh Griffith |
Employees in the company |
29 |
Shares |
52 M |
Market Cap[1] |
$ 62.4 M |
EBITDA (LTM) |
$ -41.8 M |
P/E (LTM) |
-1.89 |
P/S (LTM) |
- |
EPS (LTM) |
-0.75 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.